Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity
Isaac Dean, Colin Y. C. Lee, Zewen Kelvin Tuong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

High-dimensional single-cell analysis of human natural killer cell heterogeneity
Lucas Rebuffet, Janine Melsen, Bertrand Escalière, et al.
Nature Immunology (2024) Vol. 25, Iss. 8, pp. 1474-1488
Open Access | Times Cited: 54
Natural Killer cells at the frontline in the fight against cancer
Loïs Coënon, Mannon Geindreau, François Ghiringhelli, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 16
Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer
Vladimir Rogovskii, Vladimir V. Murugin, Nikolay Vorobyev, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 3
First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer
Roman M. Shapiro, Michal Sheffer, Matthew A. Booker, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model
Carole Fournier, Marion Mercey-Ressejac, Valentin Dérangère, et al.
EBioMedicine (2025) Vol. 112, pp. 105543-105543
Open Access | Times Cited: 2
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Colin Y. C. Lee, Bethany C. Kennedy, Nathan Richoz, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes
Wenxin Xu, G. G. Birch, Alia Meliki, et al.
ESMO Open (2025) Vol. 10, Iss. 2, pp. 104105-104105
Closed Access | Times Cited: 1
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction
Francesco Verona, Sebastiano Di Bella, Roberto Schirano, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside
Sogand Vahidi, Arefeh Zabeti Touchaei, Ali Akbar Samadani
International Immunopharmacology (2024) Vol. 133, pp. 112156-112156
Closed Access | Times Cited: 7
Immunometabolism of ferroptosis in the tumor microenvironment
Gian Luca Lupica-Tondo, Emily N. Arner, Denis A. Mogilenko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
A framework integrating multiscale in-silico modeling and experimental data predicts CD33 CAR-NK cytotoxicity across target cell types
Saeed Ahmad, Kun Xing, Harshana Rajakaruna, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Tissue-resident immune cells: from defining characteristics to roles in diseases
Jia Li, Xiao Chu, Chunxiang Li, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
The diversity of natural killer cell functional and phenotypic states in cancer
Kumar Rishabh, Sandro Matosevic
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Closed Access
There’s no place like home: How local tissue microenvironments shape the function of innate lymphoid cells
Luke B. Roberts, Alanna M. Kelly, Matthew R. Hepworth
Mucosal Immunology (2025)
Open Access
IL-15 transpresentation by ovarian cancer cells improves CD34 + progenitor-derived NK cell's anti-tumor functionality
Marcos Vidal-Manrique, Thomas Nieuwenstein, Laura Hooijmaijers, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
PLOD3 as a novel oncogene in prognostic and immune infiltration risk model based on multi-machine learning in cervical cancer
Lingling Qiu, Xinguang Qiu, Xiaoyi Yang
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells
Kaiyuan Wang, Bo Ni, Yongjie Xie, et al.
Cell Research (2025)
Closed Access
Transcriptional signature of rapidly responding NK cells reveals S1P5 and CXCR4 as anti-tumor response disruptors
Marta Puig-Gámez, Martijn Van Attekum, Torsten Theis, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways
Bailin He, Hong Chen, Jiaxu Wu, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cells
Elias Brauneck, Leon-Gordian Leonhardt, Anne Marie Assemissen, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 6
Open Access
Contemporary Approaches to Immunotherapy of Solid Tumors
A. V. Kuznetsova, Ksenia А. Glukhova, О. П. Попова, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2270-2270
Open Access | Times Cited: 3
NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer
Chrispus Ngule, Ruyi Shi, Xingcong Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
Sébastien Viel, Éric Vivier, Thierry Walzer, et al.
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 2
Autocrine TGF-β1 drives tissue-specific differentiation and function of resident NK cells
Colin Sparano, Darío Solís-Sayago, Nathan Zangger, et al.
The Journal of Experimental Medicine (2024) Vol. 222, Iss. 3
Closed Access | Times Cited: 2
Decoding changes in tumor‐infiltrating leukocytes through dynamic experimental models and single‐cell technologies
Colin Y. C. Lee, Menna R. Clatworthy, David R. Withers
Immunology and Cell Biology (2024) Vol. 102, Iss. 8, pp. 665-679
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top